Insiders Seeing Green With VRX At New 52-Week High

Shutterstock photo

In trading on Wednesday, shares of Valeant Pharmaceuticals International Inc (Symbol: VRX) touched a new 52-week high of $25.23/share. That's a 130.62% rise, or $14.29 per share from the 52-week low of $10.94 set back on 11/02/2017. That means at today's intraday high, any investor who purchased VRX stock any time over the past 52 weeks has an unrealized gain, including company insiders.

Over the past six months, insiders have been scooping up shares, and those bets are now paying off handsomely. As summarized by the table below, VRX has seen 3 different instances of insiders buying over the trailing six month period.

Purchased Insider Title Shares Price/Share Value
03/13/2018 Paul Herendeen EVP and CFO 15,000 $16.10 $241,470.00
03/13/2018 Joseph C. Papa CHAIRMAN & CEO 30,000 $16.05 $481,500.00
05/15/2018 Richard U. De Schutter Director 15,000 $21.83 $327,450.00

The chart below shows where VRX has traded over the past year, with the 50-day and 200-day moving averages included.

Valeant Pharmaceuticals International Inc Moving Averages Chart

In afternoon trading on Wednesday, VRX shares are changing hands at $24.97/share, slightly below the new 52-week high.

Ten Bargains You Can Buy Cheaper Than The Insiders Did ยป

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing

More from BNK Invest


BNK Invest

BNK Invest

Market News, Investing

Research Brokers before you trade

Want to trade FX?